An interventional study of EEG guided anesthesia and Conventional anesthesia in Anesthesia, General, Electroencephalography and Infant, sponsored by Seoul National University Hospital. Recruiting at 1 site in South Korea. Open to participants aged Up to 12 Months. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is a randomized controlled trial to evaluate whether EEG-guided calibration of inhalation agents can reduce occurrence of EEG discontinuity in infants during general anesthesia.
This is a study for comparison of incidence of EEG discontinuity during general anesthesia using sevoflurane. EEG guidance group will receive calibration of fraction of inhalational sevoflurane according to components of slow wave and delta wave of raw EEG. Control group will receive conventional management of anesthesia according to vital signs.
Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 276 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adjustment of concentration of sevoflurane according to EEG
Procedure: EEG guided anesthesia
Adjustment of concentration of sevoflurane according to vital signs
Procedure: Conventional anesthesia
Monitoring of electroencephalogram via Sedline probe by MASIMO corporation. Adjust concentration of inhalational sevoflurane during anesthesia, according to component of slow\&delta wave and alpha wave, so that slow/delta oscillation (with or without alpha oscillation) is maintained.
Adjust concentration of inhalational sevoflurane during anesthesia, according to vital signs, so that mean blood pressure and heart rate are maintained between 80% and 120% of baseline values measured at ward before anesthesia.
EEG discontinuity
Incidence of EEG discontinuity (EEG amplitudes \< 25uV for more than 2 seconds)
Time frame: From start of anesthesia to end of anesthesia, Less than 24 hours
Total duration of EEG discontinuity
Total sum of duration of EEG discontinuity
Time frame: From start of anesthesia to end of study, Less than 24 hours
Significant isoelectric EEG
Incidence of significant isoelectric EEG (EEG amplitudes \< 10uV for more than 2 seconds)
Time frame: From start of anesthesia to end of study, Less than 24 hours
EtSev
Mean end-tidal sevoflurane concentration during anesthesia
Time frame: From start of anesthesia to end of study, Less than 24 hours
SEF
Mean spectral edge frequency value during anesthesia
Time frame: From start of anesthesia to end of study, Less than 24 hours
PSi
Mean patient state index value during anesthesia
Time frame: From start of anesthesia to end of study, Less than 24 hours
Mean blood pressure
Mean blood pressure values during anesthesia measured every 2.5 minutes
Time frame: From start of anesthesia to end of study, Less than 24 hours
Heart rate
Heart rate values during anesthesia measured every 2.5 minutes
Time frame: From start of anesthesia to end of study, Less than 24 hours
Plan to share: No
Started Jun 2023 (actual). Primary completion is estimated for Mar 2027, 45 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Mar 2025 → Mar 2027 and completion May 2025 → May 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →